Concepedia

Simon Hawkins

SH

4

Publications

243

Citations

4

H-Index

2018

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Research Triangle Park Foundation

Quotient Clinical (United Kingdom)

Simon Hawkins is an author at GlaxoSmithKline (United States) specializing in engineering, medicine, and neurophysiology.

ORCID

Top concepts

Publications per year

2018–2022

4

Publications

4

Nanoparticle-induced neuronal toxicity across placental barriers is mediated by autophagy and dependent on astrocytes

Simon Hawkins, Lucy Crompton, Aman Sood et al. · Nature Nanotechnology · 2018 · 136 citations · Full text

, , +10

A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis

Kathy Weisel, Nicola Scott, Scott B. Berger et al. · BMJ Open Gastroenterology · 2021 · 85 citations · Full text

Development of a Prototype, Once-Daily, Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772

Debra Tompson, Mark Whitaker, Rennan Pan et al. · Pharmaceutical Research · 2021 · 11 citations · Full text

Development of a Once-Daily Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772 using DiffCORE Technology

Debra Tompson, Mark Whitaker, Rennan Pan et al. · Pharmaceutical Research · 2022 · 11 citations · Full text

Rows per page

1–4 of 4